Trial Profile
A phase III study of entecavir vs lamivudine in chronic hepatitis B subjects with incomplete response to lamivudine
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Apr 2011
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms BEHoLD
- 01 Jul 2008 96-week results published in Hepatology.
- 20 Oct 2005 New trial record.